Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Invasive Breast Cancer × Albumin-Bound Paclitaxel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 65 Pancreatic Neoplasms 47 Carcinoma, Non-Small-Cell Lung 28 Triple Negative Breast Neoplasms 24 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Ovarian Neoplasms 11 Lung Neoplasms 10 Esophageal Neoplasms 10 Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Stomach Neoplasms 8 Melanoma 7 Uterine Cervical Neoplasms 6 Head and Neck Neoplasms 6 Cholangiocarcinoma 6 Small Cell Lung Carcinoma 5 Recurrence 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Adenocarcinoma 4 Inflammatory Breast Neoplasms 4 Advanced Pancreatic Cancer 4 Sarcoma 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Uveal Melanoma 2

Interventions

liposomal doxorubicin 1 cemiplimab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡